National Planning Corporation’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,453
Closed -$419K 423
2017
Q3
$419K Buy
5,453
+169
+3% +$12.8K 0.04% 411
2017
Q2
$396K Sell
5,284
-10,635
-67% -$754K 0.03% 474
2017
Q1
$1.07M Sell
15,919
-25
-0.2% -$1.67K 0.08% 233
2016
Q4
$1.04M Sell
15,944
-107
-0.7% -$6.94K 0.08% 229
2016
Q3
$1.02M Sell
16,051
-2,908
-15% -$212K 0.08% 234
2016
Q2
$1.41M Sell
18,959
-2,592
-12% -$179K 0.11% 191
2016
Q1
$1.41M Sell
21,551
-675
-3% -$45.9K 0.12% 176
2015
Q4
$1.48M Buy
22,226
+2,102
+10% +$167K 0.12% 193
2015
Q3
$1.62M Sell
20,124
-4,924
-20% -$438K 0.15% 152
2015
Q2
$2.29M Buy
25,048
+1,234
+5% +$113K 0.21% 106
2015
Q1
$2.18M Buy
23,814
+2,535
+12% +$225K 0.19% 113
2014
Q4
$1.76M Sell
21,279
-1,664
-7% -$138K 0.12% 158
2014
Q3
$1.9M Buy
22,943
+517
+2% +$41.8K 0.14% 141
2014
Q2
$1.82M Buy
22,426
+2,100
+10% +$165K 0.14% 145
2014
Q1
$1.54M Buy
20,326
+1,678
+9% +$122K 0.13% 159
2013
Q4
$1.34M Buy
18,648
+2,927
+19% +$203K 0.12% 189
2013
Q3
$1.09M Buy
15,721
+6,052
+63% +$400K 0.11% 204
2013
Q2
$612K Buy
+9,669
New +$629K 0.08% 250

Other funds holding NVS

National Planning Corporation's NVS Position: Q4 2017 in Review

National Planning Corporation sold out of Novartis (NVS) in Q4 2017, closing a stake of 5,453 shares — an estimated $419K sold.

National Planning Corporation first reported a position in NVS in Q2 2013 and held it in 18 quarters. The position peaked at $2.29M in Q2 2015. 1,006 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

  • National Planning Corporation reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 5,453 Novartis shares in Q4 2017, an estimated $419K.
  • National Planning Corporation first reported a position in Novartis in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Novartis position peaked at $2.29M in Q2 2015.
  • 1,006 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.